z-logo
open-access-imgOpen Access
U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
Author(s) -
Marie R. Griffin,
Yuwei Zhu,
Matthew R. Moore,
Cynthia G. Whitney,
Carlos G. Grijalva
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1209165
Subject(s) - medicine , pneumonia , pneumococcal conjugate vaccine , pediatrics , incidence (geometry) , vaccination , confidence interval , pneumococcal pneumonia , empyema , streptococcus pneumoniae , meningitis , antibiotics , surgery , immunology , physics , optics , biology , microbiology and biotechnology
The introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into the U.S. childhood immunization schedule in 2000 has substantially reduced the incidence of vaccine-serotype invasive pneumococcal disease in young children and in unvaccinated older children and adults. By 2004, hospitalizations associated with pneumonia from any cause had also declined markedly among young children. Because of concerns about increases in disease caused by nonvaccine serotypes, we wanted to determine whether the reduction in pneumonia-related hospitalizations among young children had been sustained through 2009 and whether such hospitalizations in older age groups had also declined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom